• Media type: E-Article
  • Title: Novel Mutation in Potassium Channel related Gene KCTD7 and Progressive Myoclonic Epilepsy
  • Contributor: Krabichler, Birgit; Rostasy, Kevin; Baumann, Matthias; Karall, Daniela; Scholl‐Bürgi, Sabine; Schwarzer, Christoph; Gautsch, Kurt; Spreiz, Ana; Kotzot, Dieter; Zschocke, Johannes; Fauth, Christine; Haberlandt, Edda
  • imprint: Wiley, 2012
  • Published in: Annals of Human Genetics
  • Language: English
  • DOI: 10.1111/j.1469-1809.2012.00710.x
  • ISSN: 0003-4800; 1469-1809
  • Keywords: Genetics (clinical) ; Genetics
  • Origination:
  • Footnote:
  • Description: <jats:title>Summary</jats:title><jats:p>Progressive myoclonic epilepsy (PME) is a heterogeneous group of epilepsies characterized by myoclonus, seizures and progressive neurological symptoms.</jats:p><jats:p>The index patient was a 6‐year old boy showing early‐onset therapy resistant PME and severe developmental delay. Genome‐wide linkage analysis identified several candidate regions. The potassium channel tetramerization domain containing 7 gene (<jats:italic>KCTD7</jats:italic>) in the 7q11.21 linkage region emerged as a suitable candidate. Sequence analysis revealed a novel homozygous missense mutation (p.R94W) in a highly conserved segment of exon 2.</jats:p><jats:p>This is the second family with PME caused by <jats:italic>KCTD7</jats:italic> mutations, hence <jats:italic>KCTD7</jats:italic> mutations might be a recurrent cause of PME.</jats:p>